Delivery Order SPE2DR25D3401-SPE2DR26FL0HF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,897.86 firm fixed-price delivery order is for the supply of 4,558,571,276 units of Acamprosate Calcium Delayed-Release 333 mg Tablets in a 180-count bottle. The award has an ultimate completion date of September 26, 2022 and was issued on September 23, 2022. No set-aside designation was used for this...
- Amerisourcebergen Drug Corp has received a $28,721.98 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 180 count bottles of Acamprosate Calcium 333 mg tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania with completion by February 23, 2022. As a leading pharmaceutical distributor, Amerisourcebergen Drug Corp regularly obtains delivery orders to supply medications and medical supplies to DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency (DLA) on October 20, 2025, for the supply of Attruby 356 mg tablets (28-count packages). This firm fixed-price delivery order, with an ultimate completion date of November 10, 2025, represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,778.22 by the Defense Logistics Agency for the supply of Attruby 356 mg tablets (28-count packages) with a firm fixed price structure. The award, made on May 8, 2025, carries an ultimate completion date of May 30, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,510.20 by the Defense Logistics Agency Medical Supply Chain on December 9, 2025. This firm fixed-price delivery order, which serves as a child contract under a larger vehicle, has an ultimate completion date of December 10, 2025. The award was made through competitive procedures with no set-aside designation, reflecting the company's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $114,036.72 by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by December 16, 2025. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $174,462.87 on December 13, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is a child of a larger indefinite delivery contract, has an ultimate completion date of December 15, 2025. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,523.18 by the Defense Logistics Agency (DLA) on December 8, 2025. This competitive award utilizes firm fixed pricing and is issued as a child contract under a larger vehicle. The delivery order represents a continuation of the company's role as a critical pharmaceutical distributor supporting federal medical procurement, with performance occurring at the company's Conshohocken...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,643.64 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025. This firm fixed price delivery order, designated as a child contract, represents a non-competitive award executed under an existing contract vehicle and reflects the contractor's continued role in supplying pharmaceutical products and medical supplies to federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,468.57 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price delivery order, which is a child contract under a larger vehicle, will be performed at the company's Conshohocken facility and is scheduled for completion by August 26, 2025. The award was made through competitive procurement with no...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0HFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Acamprosate Calcium 333 mg tablets (180-count) at a ceiling value of $1,124.80. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and serves critical roles in supporting the Defense Health Agency and other government healthcare systems. The company's demonstrated capability to compete for and fulfill federal pharmaceutical procurement requirements is reflected in its consistent receipt of competitively awarded, non-set-aside delivery orders across multiple therapeutic domains, ranging from specialty medications to generic pharmaceuticals and medical supplies. This award continues the company's substantial role as a key supplier to the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/30/25 |